Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Gynecologic oncology (Print)

Results: 1-25/373

Authors: Kieback, DG Fischer, DC
Citation: Dg. Kieback et Dc. Fischer, Gene expression profile in endometrioid endometrial carcinoma, GYNECOL ONC, 83(2), 2001, pp. 175-176

Authors: Mutter, GL Baak, JPA Fitzgerald, JT Gray, R Neuberg, D Kust, GA Gentleman, R Gullans, SR Wei, LJ Wilcox, M
Citation: Gl. Mutter et al., Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation, GYNECOL ONC, 83(2), 2001, pp. 177-185

Authors: Kupets, R Covens, A
Citation: R. Kupets et A. Covens, Strategies for the implementation of cervical and breast cancer screening of women by primary care physicians, GYNECOL ONC, 83(2), 2001, pp. 186-197

Authors: Tournigand, C Louvet, C Molitor, JL Dehni, N Lejeune, V Sezeur, A Pigne, A Marpeau, L Cady, J de Gramont, A
Citation: C. Tournigand et al., Intravenous chemotherapy, early debulking surgery, and consolidation intraperitoneal chemotherapy in advanced ovarian carcinoma, GYNECOL ONC, 83(2), 2001, pp. 198-204

Authors: Shimabukuro, K Ichinose, S Koike, R Kubota, T Yamaguchi, M Miyasaka, M Aso, T
Citation: K. Shimabukuro et al., Hepatocyte growth factor/scatter factor is implicated in the mode of stromal invasion of uterine squamous cervical cancer, GYNECOL ONC, 83(2), 2001, pp. 205-215

Authors: Straughn, JM Richter, HE Conner, MG Meleth, S Barnes, MN
Citation: Jm. Straughn et al., Predictors of outcome in small cell carcinoma of the cervix - A case series, GYNECOL ONC, 83(2), 2001, pp. 216-220

Authors: Arikan, G Reich, O Weiss, U Hahn, T Reinisch, S Tamussino, K Pickel, H Desoye, G
Citation: G. Arikan et al., Are endometrial carcinoma cells disseminated at hysteroscopy functionally viable?, GYNECOL ONC, 83(2), 2001, pp. 221-226

Authors: Wobus, M Kuns, R Wolf, C Horn, LC Kohler, U Sheyn, I Werness, BA Sherman, LS
Citation: M. Wobus et al., CD44 mediates constitutive type I receptor signaling in cervical carcinomacells, GYNECOL ONC, 83(2), 2001, pp. 227-234

Authors: Hazelbag, S Fleuren, GJ Baelde, JJ Schuuring, E Kenter, GG Gorter, A
Citation: S. Hazelbag et al., Cytokine profile of cervical cancer cells, GYNECOL ONC, 83(2), 2001, pp. 235-243

Authors: Schindl, M Birner, P Breitenecker, G Oberhuber, G
Citation: M. Schindl et al., Downregulation of KAI1 metastasis suppressor protein is associated with a dismal prognosis in epithelial ovarian cancer, GYNECOL ONC, 83(2), 2001, pp. 244-248

Authors: Davidson, B Risberg, B Berner, A Nesland, JM Trope, CG Kristensen, GB Bryne, M Goscinski, M de Putte, GV Florenes, VA
Citation: B. Davidson et al., Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications, GYNECOL ONC, 83(2), 2001, pp. 249-256

Authors: Rodriguez, M Rose, PG
Citation: M. Rodriguez et Pg. Rose, Improved therapeutic index of lower dose topotecan chemotherapy in recurrent ovarian cancer, GYNECOL ONC, 83(2), 2001, pp. 257-262

Authors: Aoki, Y Tomita, M Sato, T Watanabe, M Kase, H Fujita, K Kurata, H Tanaka, K
Citation: Y. Aoki et al., Neoadjuvant chemotherapy for patients younger than 50 years with high-risksquamous cell carcinoma of the cervix, GYNECOL ONC, 83(2), 2001, pp. 263-267

Authors: Curtin, JP Blessing, JA Soper, JT DeGeest, K
Citation: Jp. Curtin et al., Paclitaxel in the treatment of carcinosarcoma of the uterus: A gynecologiconcology group study, GYNECOL ONC, 83(2), 2001, pp. 268-270

Authors: Ghosh, K Padilla, LA Murray, KP Downs, LS Carson, LF Dusenbery, KE
Citation: K. Ghosh et al., Using a belly board device to reduce the small bowel volume within pelvic radiation fields in women with postoperatively treated cervical carcinoma, GYNECOL ONC, 83(2), 2001, pp. 271-275

Authors: Levenback, C Coleman, RL Burke, TW Bodurka-Bevers, D Wolf, JK Gershenson, DM
Citation: C. Levenback et al., Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer, GYNECOL ONC, 83(2), 2001, pp. 276-281

Authors: Seago, DP Raman, A Lele, S
Citation: Dp. Seago et al., Potential benefit of lymphadenectomy for the treatment of node-negative locally advanced uterine cancers, GYNECOL ONC, 83(2), 2001, pp. 282-285

Authors: Jaeger, W Ackermann, S Kessler, H Katalinic, A Lang, N
Citation: W. Jaeger et al., The effect of bowel resection on survival in advanced epithelial ovarian cancer, GYNECOL ONC, 83(2), 2001, pp. 286-291

Authors: Hurteau, JA Allison, BM Brutkiewicz, SA Goebl, MG Heilman, DK Bigsby, RM Harrington, MA
Citation: Ja. Hurteau et al., Expression and subcellular localization of the cyclin-dependent kinase inhibitor p27(Kip1) in epithelial ovarian cancer, GYNECOL ONC, 83(2), 2001, pp. 292-298

Authors: Guerriero, S Alcazar, JL Ajossa, S Lai, MP Errasti, T Mallarini, G Melis, GB
Citation: S. Guerriero et al., Comparison of conventional color Doppler imaging and power Doppler imagingfor the diagnosis of ovarian cancer: Results of a European study, GYNECOL ONC, 83(2), 2001, pp. 299-304

Authors: Mahmoud-Ahmed, AS Suh, JH Barnett, GH Webster, KD Belinson, JL Kennedy, AW
Citation: As. Mahmoud-ahmed et al., The effect of radiation therapy on brain metastases from endometrial carcinoma: A retrospective study, GYNECOL ONC, 83(2), 2001, pp. 305-309

Authors: Zimny, M Siggelkow, W Schroder, W Nowak, B Biemann, S Rath, W Buell, U
Citation: M. Zimny et al., 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of recurrent ovarian cancer, GYNECOL ONC, 83(2), 2001, pp. 310-315

Authors: Abramov, Y Anteby, SO Fatum, M Fasouliotis, SJ Barak, V
Citation: Y. Abramov et al., The kinetics of leptin in Meigs' syndrome, GYNECOL ONC, 83(2), 2001, pp. 316-318

Authors: Scambia, G Ferrandina, G Distefano, M Fagotti, A Manfredi, R Zannoni, GF Mancuso, S
Citation: G. Scambia et al., Is there a place for a less extensive radical surgery in locally advanced cervical cancer patients?, GYNECOL ONC, 83(2), 2001, pp. 319-324

Authors: Jin, MS Udagawa, K Miyagi, E Nakazawa, T Hirahara, F Yasumitsu, H Miyazaki, K Nagashima, Y Aoki, I Miyagi, Y
Citation: Ms. Jin et al., Expression of serine proteinase inhibitor PP5/TFPI-2/MSPI decreases the invasive potential of human choriocarcinoma cells in vitro and in vivo, GYNECOL ONC, 83(2), 2001, pp. 325-333
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>